A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C
Clinical trial NCT01908335 · COMPLETED
Trial details
- NCT number
- NCT01908335
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-08-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.